Growth Metrics

Akari Therapeutics (AKTX) Non-cash Items (2014 - 2026)

Akari Therapeutics recorded quarterly Non-cash Items of $88604.0 in Q1 2026, down 95.93% quarter-over-quarter from $2.2 million in Q3 2025, and up 8860300.0% year-over-year from N/an in Q1 2025.

Akari Therapeutics' Non-cash Items history runs 13 years deep, the most recent figure standing at $88604.0 for Q1 2026.

  • In Q1 2026, Non-cash Items rose 8860300.0% year-over-year to $88604.0; the TTM figure through Mar 2026 stood at $88604.0 (up 8860300.0% YoY), while the FY2024 annual figure was $3.0 million, down 98.59% from the prior year.
  • Non-cash Items came in at $88604.0 for Q1 2026 at Akari Therapeutics, down from $2.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $263.1 million in Q2 2024 to a low of -$2.8 million in Q2 2022.
  • A 5-year average of $70.3 million and a median of $1.6 million in 2025 frame the typical range for Non-cash Items.
  • On a YoY basis, Non-cash Items climbed as much as 108870950.0% in 2025 and fell as far as 100.0% in 2025.
  • Akari Therapeutics' Non-cash Items stood at $128.5 million in 2022, then jumped by 65.44% to $212.5 million in 2023, then slumped by 98.59% to $3.0 million in 2024, then declined by 27.32% to $2.2 million in 2025, then slumped by 95.93% to $88604.0 in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods registered $88604.0, $2.2 million, and $1.0 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 88,604.00
Mar 31, 2026 88,604.00
Sep 30, 2025 2.18 Mn
Sep 30, 2025 2.18 Mn
Jun 30, 2025 1.04 Mn
Jun 30, 2025 1.04 Mn
Mar 31, 2025 1.60 Bn
Mar 31, 2025 1.60 Bn
Dec 31, 2024 3.00 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 2.00
Sep 30, 2024 2.00
Jun 30, 2024 263.10 Mn
Jun 30, 2024 263.10 Mn
Mar 31, 2024 236.43 Mn
Mar 31, 2024 236.43 Mn
Dec 31, 2023 212.51 Mn
Dec 31, 2023 212.51 Mn
Dec 31, 2022 128.45 Mn
Dec 31, 2022 128.45 Mn
Jun 30, 2022 -2.77 Mn
Jun 30, 2022 -2.77 Mn
Mar 31, 2022 126,784.00
Mar 31, 2022 126,784.00
Sep 30, 2021 -2,206.46 Bn
Sep 30, 2021 -2,206.46 Bn
Jun 30, 2021 -2.10 Mn
Jun 30, 2021 -2.10 Mn
Mar 31, 2021 -1.58 Mn
Mar 31, 2021 -1.58 Mn
Dec 31, 2020 2.58 Mn
Dec 31, 2020 2.58 Mn
Sep 30, 2020 -2,445.52 Bn
Sep 30, 2020 -2,445.52 Bn
Jun 30, 2020 -827,896.00
Jun 30, 2020 -827,896.00
Mar 31, 2020 -3,994.25 Bn
Mar 31, 2020 -3,994.25 Bn
Dec 31, 2019 4.37 Mn
Dec 31, 2019 4.37 Mn
Sep 30, 2019 -226,294.00
Sep 30, 2019 -226,294.00
Jun 30, 2019 2.12 Mn
Jun 30, 2019 2.12 Mn
Mar 31, 2019 415,455.00
Mar 31, 2019 415,455.00
Sep 30, 2018 -5.06 Mn
Sep 30, 2018 -5.06 Mn
Jun 30, 2018 -3.32 Mn
Jun 30, 2018 -3.32 Mn
Mar 31, 2018 -3.06 Mn
Mar 31, 2018 -3.06 Mn
Dec 31, 2017 266,011.00
Dec 31, 2017 266,011.00
Sep 30, 2017 199,736.00
Sep 30, 2017 199,736.00
Jun 30, 2017 -962,653.00
Jun 30, 2017 -962,653.00
Mar 31, 2017 3.42 Mn
Mar 31, 2017 3.42 Mn
Sep 30, 2016 -8.28 Mn
Sep 30, 2016 -8.28 Mn
Jun 30, 2016 -3.70 Mn
Jun 30, 2016 -3.70 Mn
Mar 31, 2016 -4.46 Mn
Mar 31, 2016 -4.46 Mn
Dec 31, 2015 -13.24 Mn
Dec 31, 2015 -13.24 Mn
Jun 30, 2015 351,533.00
Jun 30, 2015 351,533.00
Mar 31, 2015 -291,692.00
Mar 31, 2015 -291,692.00
Dec 31, 2014 445,833.00
Dec 31, 2014 445,833.00